Pharmaceutical Products Supply
Titre original de l'avis
Bulgaria – Pharmaceutical products – „Доставка на лекарствени продукти за нуждите на МБАЛ “Д-р Братан Шукеров”АД“
Score d'opportunité
Pourquoi ce score ?
Opportunité
70 / 100
Complexité
60 / 100
Facteurs de risque
Stringent licensing requirements may exclude non-Bulgarian entities without proper authorization.
Structured data indicates EU funding, but XML notice states no EU funds. This inconsistency could affect contract fundi...
Restricted procedure — pre-qualification required
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Informations clés
- Pouvoir adjudicateur
- МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - Д-Р БРАТАН ШУКЕРОВ АД
- Pays
- Bulgarie
- CPV
- 33600000 - Pharmaceutical products
- Date limite
- Jun 24, 2027
- Valeur estimée
- BGN 8.4M
Aperçu
Moderate opportunityFaits clés
- BGN 8.4M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Supply of pharmaceutical products as defined in the technical specification.
- Estimated quantities are provided but not guaranteed.
Afficher le résumé complet
This tender is a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products to MBAL Dr. Bratan Shukerov AD in Smolyan, Bulgaria. The estimated total value is 8,416,335 BGN for a 24-month period. The procedure is restricted, with award based on lowest price. The deadline for initial applications is 24 June 2027, far in the future, suggesting a long-term DPS. Key eligibility requires valid manufacturing or wholesale authorization for medicinal products in Bulgaria or EU equivalent. Note: There is an inconsistency regarding EU funding—structured data indicates EU-funded, but the XML notice states no EU funds.
Risques
Stringent licensing requirements may exclude non-Bulgarian entities without proper authorization.
Structured data indicates EU funding, but XML notice states no EU funds. This inconsistency could affect contract fundi...
Restricted procedure — pre-qualification required
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- Must hold valid manufacturing or wholesale authorization for medicinal products in Bulgaria or EU equivalent.
- Compliance with Bulgarian Medicines Act (ZLPHM).
- Candidates must apply for inclusion in the DPS; initial application required.
Les exigences peuvent être incomplètes.
Critères d'attribution
Lot 1
Acheteur
Localisation
гр. Смолян, BGR
Site web
Profil acheteur
Identifiant
120503871
Activité
Health
Lots (1)
LOT-0001
Pharmaceutical Products Supply
Supply of medicinal products as per the technical specification (not analyzed). Quantities are estimated and not guaranteed. The DPS runs for 24 months from September 2024.
BGN 8.4M
Valeur estimée
Localisation
Durée
Catégorie
Critères d'attribution
Détails des critères
Обществената поръчка ще се възложи въз основа на икономически най-изгодната оферта при критерий за възлагане „най-ниска цена”
Note sur la valeur
Afficher les données TED originales
Titre original du lot
„Доставка на лекарствени продукти за нуждите на МБАЛ “Д-р Братан Шукеров”АД“
Description TED originale
„Доставка на лекарствени продукти за нуждите на МБАЛ “Д-р Братан Шукеров”АД“. Лекарствените продукти са посочени по номенклатурни единици и са подробно представени по лекарствени форми, количество лекарствено вещество, единица мярка и необходимо прогнозно количество в приложената към документацията първоначална „Техническа спецификация“. Посочените количества в приложената към документацията „Техническа спецификация“ са прогнозни и не задължават Възложителя да ги закупи в пълен обем, а съобразно своята необходимост.
Détails de la procédure
- Date de publication
- 26 Jun 2024
- Langues
- Bulgarian
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 377194-2024
Documents (1)
Appels d'offres similaires
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Score d'opportunité
Pourquoi ce score ?
Opportunité
70 / 100
Complexité
60 / 100
Facteurs de risque
Stringent licensing requirements may exclude non-Bulgarian entities without proper authorization.
Structured data indicates EU funding, but XML notice states no EU funds. This inconsistency could affect contract fundi...
Restricted procedure — pre-qualification required
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications